Related Experiment Video
Updated: Jun 21, 2026

Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
Hypertension after pediatric cardiac transplantation: detection, etiology, implications and management
S Lucy Roche1, John J O'Sullivan, Paul F Kantor
1Department of Pediatric Cardiology, The Hospital for Sick Children, Toronto, ON, Canada.
Insights
Pediatric heart transplant recipients often develop hypertension, a serious complication impacting survival. This review explores causes, monitoring, and treatment of this condition in children post-transplant.
Area of Science:
- Pediatric Cardiology
- Transplant Medicine
- Hypertension Research
Background:
- Cardiac transplantation is life-saving for children with end-stage heart failure.
- A significant majority (50-70%) of pediatric recipients develop new-onset hypertension post-transplant.
- Uncontrolled hypertension poses risks to graft and patient survival due to vulnerable heart and kidney systems.
Purpose of the Study:
- To review the multi-factorial etiology of post-transplant hypertension in pediatric cardiac recipients.
- To highlight current uncertainties and specific mechanisms of hypertension in this population.
- To discuss optimal blood pressure (BP) monitoring and treatment strategies.
Main Methods:
- Literature review focusing on post-cardiac transplant hypertension in children.
- Analysis of etiological factors, monitoring techniques, and therapeutic interventions.
- Emphasis on mechanisms unique to cardiac recipients and specific treatment cautions.
Main Results:
- Post-transplant hypertension is a common and serious complication in pediatric cardiac recipients.
- Multiple factors contribute to hypertension, with specific mechanisms requiring further investigation.
- 24-hour ambulatory blood pressure (ABP) monitoring offers advantages over intermittent clinic measurements.
- Antihypertensive prescribing requires specific cautions in this vulnerable population.
Conclusions:
- Effective management of post-transplant hypertension is crucial for improving long-term outcomes in pediatric cardiac recipients.
- Further research is needed to fully elucidate the multifactorial etiology and optimize treatment.
- Close monitoring, particularly using 24-hour ABP, and careful medication selection are essential.
Abstract:
While it may rescue children with end-stage heart failure from impending catastrophe, cardiac transplantation leaves 50-70% of pediatric recipients with new-onset hypertension. Given the unique vulnerability of the heart and kidneys in these children, we can expect long-term uncontrolled hypertension to shorten both graft and patient survival. In this review we discuss the multi-factorial etiology of post-transplant hypertension, highlighting current uncertainties and emphasizing mechanisms specific to cardiac recipients. We consider the optimal means of monitoring BP and in particular, the advantages of 24 h-ABP over intermittent clinic measurements. We also review BP treatment after cardiac transplantation, drawing attention to specific cautions appropriate when prescribing antihypertensive agents in these circumstances.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertension I: Introduction
Kidney Transplant I: Introduction

